Emerging therapeutic approaches in the management of retinal angiogenesis and edema - PubMed (original) (raw)

Review

Emerging therapeutic approaches in the management of retinal angiogenesis and edema

An Truong et al. J Mol Med (Berl). 2011 Apr.

Abstract

Conditions resulting in retinal angiogenesis and edema (exudative age-related macular degeneration, diabetic retinopathy, retinal vein occlusion and retinopathy of prematurity) are major causes of visual impairment, with significant impact on quality of life. There has been increasing clinical usage of anti-vascular endothelial growth factor (anti-VEGF) agents to stop retinal angiogenesis and resolve intraretinal fluid arising from these conditions. However, anti-VEGFs have not been completely successful in curing these conditions, and a range of emerging treatments aimed at supplementing or competing with anti-VEGF agents are being developed. We will discuss the proposed merits these emerging agents bring to the treatment arsenal and how they compare with anti-VEGFs with regards to therapeutic activity, potency, specificity and safety. This review will also highlight recent pre-clinical research findings and suggest where future research might be directed.

PubMed Disclaimer

References

    1. N Engl J Med. 2006 Oct 5;355(14):1419-31 - PubMed
    1. JAMA. 2007 Aug 22;298(8):902-16 - PubMed
    1. Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1606-8 - PubMed
    1. Ann N Y Acad Sci. 1995 Nov 27;772:30-9 - PubMed
    1. Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17456-61 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources